Criminal defendants still cite a ‘gene for violence.’ It doesn’t exist.
By Nita Farahany and Gene E. Robinson,
The Washington Post
| 03. 18. 2021
The New Mexico Supreme Court ruled last month on an extraordinarily important question: Should a criminal defendant be allowed to argue that a specific gene rendered him unable to control his violent behavior? The court concluded the answer was no, in this instance: It upheld the conviction for second-degree murder of Anthony Blas Yepez, who killed a man in 2012. Yepez had sought at trial to introduce evidence that he had what’s been called the “warrior gene” — a version of a gene known as MAOA, which has been linked to violence in some studies. The district court of Sante Fe County excluded expert testimony on that subject; later, the New Mexico appellate court ruled that the exclusion was a mistake but that it did not affect the outcome of the trial. The New Mexico Supreme Court has now found that the district court’s original rejection of the evidence was reasonable.
The state Supreme Court, however, missed an important opportunity: It did not go nearly far enough in batting down the scientifically suspect claim that there is a gene...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...